Frontline Plus

Jump to

Will file appeal in US court on drug patent breach: Cipla

A US District Court has ordered the seizure of a drug made by Cipla and sold by Velecra. S Radhakrishnan, CFO, Cipla has clarified on CNBC-TV18 that they are in process of filing an appeal within the next 60 days.
US court seizes veterinary drug produced by Cipla

Sanofi Aventis recently announced that a US Court has ordered the seizure of Frontline Plus, a drug produced by Cipla and sold by Velecra. On the back of this, the share price of Cipla has fallen around 1.5%.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Frontline Plus

Will file appeal in US court on drug patent breach: Cipla

US court seizes veterinary drug produced by Cipla